Ann: Imagion and Patrys collaborate on new cancer imaging agents, page-53

Yes, and any positive news on the recruitment front will also likely cause the stock to re-rate back above 10cents.

Therefore, if you own the stock or are thinking about buying it... is it truly feasible that they'll never recruit anyone? How likely are they to find enough volunteers to complete the trial by the end of the calendar year as planned?

So yes it will still be a bumpy ride as we wait for the trial to truly commence and then to finish.